Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Pediatric acute myeloid leukemia tumor composition predicts patient outcomes at diagnosis and reveals mechanisms of resistance to chemotherapy.
Journal: Research square
Published: February 06, 2026
Population Pharmacokinetics of Bosutinib in Children with Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia Based on a Phase I Dose-Finding Trial (ITCC-054/COG AAML1921) and Pediatric Recommended Phase II Dosage Evaluation.
Journal: Clinical pharmacokinetics
Published: February 05, 2026
Characterization of Chemoresistant Cell Populations Improves Risk Stratification and Therapy Prediction in Pediatric AML.
Journal: bioRxiv : the preprint server for biology
Published: November 19, 2025
Characteristics and outcomes of newly diagnosed pediatric acute myeloid leukemia patients who were removed from standard regimens and received alternative therapy.
Journal: Haematologica
Published: January 29, 2025
Invasive Candidiasis in Pediatric Hematologic Malignancy: Increased Risk of Dissemination With Candida tropicalis.
Journal: The Pediatric infectious disease journal
Published: October 09, 2024
Identification of single-cell blasts in pediatric acute myeloid leukemia using an autoencoder.
Journal: Life science alliance
Published: February 23, 2024
Addressing a Pre-Clinical Pipeline Gap: Development of the Pediatric Acute Myeloid Leukemia Patient-Derived Xenograft Program at Texas Children's Hospital at Baylor College of Medicine.
Journal: Biomedicines
Published: December 02, 2023
Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 30, 2023
Last Updated: 09/26/2026